drugset / Trial / NCT01365338
A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary objective of this study aims to determine whether the drug affects brain activity in healthy volunteers, either when the participants are performing a memory task, or when lying at rest. Subjects will undergo a brain scan under both of these conditions after a dose of either the study drug or a placebo is administered.The secondary objective is to evaluate the safety and tolerability of the four doses of PF-04958242 administered orally to healthy adult participants.
Timeline
- Start
- 2011-06-24
- Primary completion
- 2012-12-14
- Completion
- 2012-12-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PESAMPATOR | Small molecule | 0.075 mg | Oral |
| Subject | PESAMPATOR | Small molecule | 0.15 mg | Oral |
Indications
No indication recorded.